US FDA Declines to Approve Growth Hormone Deficiency Treatment
The US health regulator has declined to approve the treatment for growth hormone deficiency in children that Pfizer developed with partner OPKO Health.
Reuters Health Information
source https://www.medscape.com/viewarticle/967079?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/967079?src=rss
Comments
Post a Comment